Autolus Therapeutics Ltd reported 266.14M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
AstraZeneca USD 1.55B 1.16B Jun/2025
Autolus Therapeutics Ltd 266.14M 266.01M Jun/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Novartis USD 793M 0 Dec/2024
Roche Holding CHF 107M 0 Jun/2024
Silence Therapeutics 7.08M 63K Sep/2024